Vanguard Group Portfolio holdings
Vanguard Group is an investment manager owned by the funds it manages, and so by its own customers. John Bogle founded it in 1975 and is credited with creating the first index fund available to individual investors. After Wellington Management fired Bogle in 1974, he started a new fund division there and named it Vanguard after HMS Vanguard, Horatio Nelson's flagship. Bogle set up its first index fund in 1976, the fund that became the Vanguard 500 Index Fund, and the firm added a bond index fund in 1986. It began offering ETFs in 2001 as exchange-traded shares of its index funds, and it also serves employers' retirement plans and independent financial advisers. Salim Ramji, who came from BlackRock, was named chief executive in 2024 as the first outsider to lead the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$8.03B |
| 2 |
Microsoft
MSFT
|
+$8B |
| 3 |
Apple
AAPL
|
+$7.21B |
| 4 |
TotalEnergies
TTE
|
+$5.18B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.85B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$2.74B |
| 2 |
DuPont de Nemours
DD
|
+$2.65B |
| 3 |
Mr. Cooper
COOP
|
+$1.41B |
| 4 |
Interpublic Group of Companies
IPG
|
+$1.24B |
| 5 |
Amazon
AMZN
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 9.9% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3126
Corbus Pharmaceuticals
CRBP
$69.9M
| $7M | ﹤0.01% |
859,407
+247,377
| +40% | +$3.05M |
2015 Q2
42 quarters
|
|
3127
DELISTED
European Wax Center
EWCZ
| $6.99M | ﹤0.01% |
1,942,439
+40,061
| +2% | +$150K |
2021 Q3
17 quarters
|
|
3128
IRulya Therapeutics Inc. Common Stock
IRLA
$431M
| $6.98M | ﹤0.01% |
10,420
+1,603
| +18% | +$807K |
2019 Q2
26 quarters
|
|
3129
Hanover Bancorp
HNVR
$156M
| $6.96M | ﹤0.01% |
301,285
+6,249
| +2% | +$139K |
2022 Q4
12 quarters
|
|
3130
eHealth
EHTH
$13.4M
| $6.95M | ﹤0.01% |
1,511,532
-14,566
| -1% | -$64.2K |
2013 Q2
50 quarters
|
|
3131
ChargePoint
CHPT
$313M
| $6.93M | ﹤0.01% |
1,043,950
+10,096
| +1% | +$95.4K |
2021 Q1
19 quarters
|
|
3132
SAB Biotherapeutics
SABS
$267M
| $6.91M | ﹤0.01% |
1,847,136
+1,481,383
| +405% | +$4.87M |
2021 Q4
16 quarters
|
|
3133
Intellicheck
IDN
$37.7M
| $6.9M | ﹤0.01% |
1,033,568
+36,075
| +4% | +$204K |
2013 Q2
50 quarters
|
|
3134
Rani Therapeutics
RANI
$60.7M
| $6.9M | ﹤0.01% |
5,109,368
+4,224,759
| +478% | +$6.37M |
2021 Q3
17 quarters
|
|
3135
LifeMD
LFMD
$106M
| $6.89M | ﹤0.01% |
2,021,704
-205,167
| -9% | -$996K |
2021 Q1
19 quarters
|
|
3136
Escalade
ESCA
$289M
| $6.88M | ﹤0.01% |
510,016
+2,243
| +0.4% | +$27.9K |
2013 Q2
50 quarters
|
|
3137
Westwood Holdings Group
WHG
$179M
| $6.86M | ﹤0.01% |
398,354
+1,089
| +0.3% | +$18.3K |
2013 Q2
50 quarters
|
|
3138
Caribou Biosciences
CRBU
$39.1M
| $6.84M | ﹤0.01% |
4,304,198
+77,272
| +2% | +$162K |
2021 Q3
17 quarters
|
|
3139
MacroGenics
MGNX
$140M
| $6.81M | ﹤0.01% |
4,226,941
+2,707
| +0.1% | +$4.26K |
2013 Q4
48 quarters
|
|
3140
Fermi Inc
FRMI
$1.67B
| $6.8M | ﹤0.01% |
+850,283
| New | +$16.6M |
2025 Q4
0 quarters
|
|
3141
Vanguard International High Dividend Yield ETF
VYMI
$22B
| $6.8M | ﹤0.01% |
75,556
+14,169
| +23% | +$1.23M |
2023 Q1
11 quarters
|
|
3142
Landmark Bancorp
LARK
$197M
| $6.79M | ﹤0.01% |
259,097
+6,794
| +3% | +$178K |
2019 Q1
27 quarters
|
|
3143
FG Communities Holdings Inc. Common Stock
FGC
$27.3M
| $6.77M | ﹤0.01% |
492,064
+486,565
| +8,848% | +$8.53M |
2014 Q2
46 quarters
|
|
3144
Genelux
GNLX
$84.2M
| $6.76M | ﹤0.01% |
1,551,449
+132,068
| +9% | +$713K |
2023 Q1
11 quarters
|
|
3145
DELISTED
Fonar
FONR
| $6.75M | ﹤0.01% |
363,788
-24,657
| -6% | -$372K |
2013 Q2
50 quarters
|
|
3146
XPLR Infrastructure LP
XIFR
$716M
| $6.74M | ﹤0.01% |
673,876
+23,342
| +4% | +$226K |
2014 Q4
44 quarters
|
|
3147
Hooker Furnishings Corp
HOFT
$158M
| $6.73M | ﹤0.01% |
596,009
+422
| +0.1% | +$4.24K |
2013 Q2
50 quarters
|
|
3148
Maui Land & Pineapple Co
MLP
$292M
| $6.7M | ﹤0.01% |
395,256
+7,631
| +2% | +$123K |
2013 Q2
50 quarters
|
|
3149
Inseego
INSG
$74.5M
| $6.68M | ﹤0.01% |
650,469
-13,191
| -2% | -$171K |
2013 Q2
50 quarters
|
|
3150
Superior Group of Companies
SGC
$225M
| $6.68M | ﹤0.01% |
689,994
-191
| -0% | -$1.87K |
2013 Q2
50 quarters
|
|
Similar funds
Vanguard Group's Q4 2025 Portfolio in Review
As of Q4 2025, Vanguard Group held 4,426 positions worth $6.9T, up 3.3% from $6.68T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4.1%. Vanguard Group opened 82 new positions and exited 98, leaving the 4,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2025 buy was TotalEnergies: 81,863,403 shares worth $5.34B.
- Vanguard Group added most to NVIDIA in Q4 2025, an estimated $8.03B increase.
- Vanguard Group's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $2.65B.
- Vanguard Group fully exited Kellanova in Q4 2025, selling an estimated $2.74B.
- Vanguard Group's ten largest holdings make up 31% of its $6.9T portfolio in Q4 2025.
- Vanguard Group opened 82 new positions and closed 98 in Q4 2025.
- Vanguard Group's portfolio value rose 3.3% quarter-over-quarter to $6.9T.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.